GENEVA, March 4 -- ELI LILLY AND COMPANY (Lilly Corporate CenterIndianapolis, Indiana 46285) filed a patent application (PCT/US2024/042615) for "AMYLOID PRECURSOR PROTEIN (APP) RNAi AGENTS" on Aug 16, 2024. With publication no. WO/2025/042709, the details related to the patent application was published on Feb 27, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): ALAM, Riazul (c/o Eli Lilly and CompanyP.O. Box 6288Indianapolis, Indiana 46206-6288), CHEN, Jee-Wei Emily (c/o Eli Lilly and CompanyP.O. Box 6288Indianapolis, Indiana 46206-6288), CROY, Carrie Hughes (c/o Eli Lilly and CompanyP.O. Box...